Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gain Therapeutics (GANX) Interest & Investment Income (2024 - 2025)

Gain Therapeutics has reported Interest & Investment Income over the past 2 years, most recently at $83339.0 for Q4 2025.

  • Quarterly results put Interest & Investment Income at $83339.0 for Q4 2025, up 60.71% from a year ago — trailing twelve months through Dec 2025 was $244394.0 (down 31.56% YoY), and the annual figure for FY2025 was $244394.0, down 31.56%.
  • Interest & Investment Income for Q4 2025 was $83339.0 at Gain Therapeutics, up from $78074.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for GANX hit a ceiling of $115303.0 in Q1 2024 and a floor of $40413.0 in Q1 2025.